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Abstract
Aims/hypothesis We reassessed the validity of previously re-
ported incidence rates for type 1 diabetes in 0–34 year olds in
Sweden. We estimated new incidence rates through three
nationwide registers.
Methods We used capture–recapture methods to assess ascer-
tainment in the Diabetes Incidence Study in Sweden (DISS)
and estimated incidence rates in the 20–34 year age group for
2007–2009. We examined whether incidence rates in patients
aged 34 and younger could be estimated through the Pre-
scribed Drug Register (PDR) via a proxy for diagnosis
of type 1 diabetes; men with at least one and women with
at least three prescriptions for insulin were included if
they had not been given oral glucose-lowering drugs. We
scrutinised the proxy by comparing incidence rates in
patients aged 14 and younger with the Swedish Childhood
Diabetes Register (SCDR), which has 95–99% ascertainment,
and by assessing diabetes type among 18–34 year olds in the
National Diabetes Register (NDR).
Results Incidence rates were two to three times higher than
previously reported. The absolute number of cases (2007–2009,
age 20–34) was 435 in the DISS, 923 in the NDR, 1,217 in the
PDR, 1,431 in all three and 1,617 per the capture–recapture
method. Ascertainment in the DISS was ~29% for 2007–2009.
The proxy diagnosis in the PDR was highly reliable, while the
capture–recapture method presumably generated an
overestimate.
Conclusions/interpretation The incidence of type 1 diabetes
in patients aged 34 and younger was two to three times higher
than previously reported. The PDR can be used to reliably
assess incidence rates in this age group.
Keywords Epidemiology . Incidence .Springharvest theory .
Type 1 diabetes
Abbreviations
CCV Coefficient of covariation
DISS Diabetes Incidence Study in Sweden
NDR National Diabetes Register
PDR Prescribed Drug Register
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Introduction
Type 1 diabetes is an epidemiological enigma. It was a rare
disease in the early twentieth century. Its incidence began to
rise in the 1950s [1]. International multicentre studies initiated
in the 1980s included subjects aged 14 and younger. The
studies have reported an annual 3% increase in the incidence
of the disease. The steepest increase has been noted in the age
range 0–4 years, and it appears that onset has shifted to
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younger age groups [2, 3]. The incidence in Europe is pre-
dicted to rise by an alarming 70% between 2005 and 2020 [3].
The explanation for this increase remains elusive. A possi-
ble hypothesis is that improved survival has increased the
prevalence of susceptible genes. However, the rapid increase
in the incidence of the disease and the striking spatiotemporal
variations cannot be explained by genetic changes alone [1, 4,
5]. It follows that environmental factors are making a major
contribution. Something has changed in our environment,
causing more individuals to develop the disease, at a younger
age and with less genetic predisposition [6, 7].
It has been postulated that the increase in patients aged 14
and younger represents a left shift in the age of onset and that
this increase is mirrored by a corresponding decrease in the
rest of the population. The competing theory states that the
incidence has risen in people aged 15 and older as well [1].
Epidemiological studies have been contradictory. Two out of
three noteworthy studies supporting a left shift in the age of
onset, without an increase in cumulative incidence, were
Swedish [8–10]. Reports from Finland [11], Italy [12] and
the UK [13], however, showed stable or increasing incidence
up to the age of 39.
Resolving these contradictions requires the use of
standardised registers with adequate age range and geographic
coverage, as well as a high level of ascertainment. Such an
approach demands initiatives and resources, and failure at any
step along the way can lead to erroneous conclusions. Indeed,
hypotheses on the spring harvest theory proceed from scarce
data for the 15–34 age group. We used three nationwide
registers and capture–recapture methods to reassess the valid-
ity of previous reports from Sweden and to estimate new
incidence rates. We also explored whether incidence could
be monitored by means of the Prescribed Drug Register
(PDR) alone.
Methods
Data sources Swedish researchers and public authorities
manage several nationwide registers that are suitable for our
aims. Linking these registers with the personal identification
number assigned to each Swede is a straightforward process.
Started in 1996, the National Diabetes Register (NDR)
covers patients aged 18 and older [14]. Data provided by
trained nurses and physicians include information obtained
at both outpatient and primary care clinics. Data are transmit-
ted seamlessly from the clinic to the NDR. Individuals with
type 1 diabetes are almost invariably treated at the outpatient
clinics of hospitals, more than 90% of which reported to the
NDR during the study period. Ninety-five percent of the
subjects of the study had been diagnosed with type 1 diabetes
on the basis of a clinical assessment. The remaining 5% were
being treated with insulin only and had developed the disease
at age 30 or younger; these sample characteristics have been
validated in 97% of cases [15]. Between 12% and 15% of
patients eligible for inclusion were excluded because of miss-
ing data for either the year of onset or type of diabetes.
The Diabetes Incidence Study in Sweden (DISS), which
began in 1983, includes incident cases of Swedes aged
15–34 years diagnosed at departments of paediatrics, internal
medicine and endocrinology [16, 17]. The patients are report-
ed on a data entry form. Each clinic appoints a physician to
serve as a contact, provide information about the DISS and
make sure that new cases are reported. Classification of the
diabetes type is based on a clinical assessment, as well as an
analysis of islet cell antibodies since 1998. We included
individuals classified as having type 1 diabetes in the DISS.
The level of ascertainment in the DISS is uncertain—previous
checks have relied on data from 1983 to 1997, includ-
ing roughly 15% of the at-risk population [8, 18]. Important-
ly, previous Swedish reports that have contributed substantial-
ly to the spring harvest theory are based on a combina-
tion of the DISS and the Swedish Childhood Diabetes Reg-
ister (SCDR).
Started in 1977, the SCDR includes patients aged 14 and
younger. The SCDR participates in international multicentre
studies and has a level of ascertainment approaching 100%
through efficient entry of incident cases, stringent validation
procedures and vigorous data collection. Although our study
did not use the SCDR, we compared our estimates with its
previous reports from 2005 to 2007 [19].
The PDR of the National Board of Health and Welfare
contains data on every prescription filled in Sweden since 1
July 2005 [20]. We used a proxy for diagnosis of type 1
diabetes in the age range 0–34 years in the PDR (database
available from 1 July 2005 to 31 December 2012). Men
receiving at least one prescription and women receiving at
least three prescriptions (thereby excluding gestational
diabetes) of insulin were classified as having type 1 diabetes
if they had never been given oral glucose-lowering drugs. The
date of receiving the first prescription was regarded as the
onset of the disease. This method was scrutinised by compar-
ing incidence rates in patients aged 14 and younger with
available figures from the SCDR in 2005–2007 [19]. We
assessed the type of diabetes in patients aged 18–34 via the
NDR if it was possible to match them there. Data in the PDR
for 2005, 2006 and 2012 were ineligible. The PDR started in
mid-2005, and cases were accumulated for 2005 and 2006.
The ineligibility of 2012 was due to missing data for 2013
(inclusion of 2013 would affect incidence rates for women
since they have to receive at least three prescriptions of
insulin). The remaining 6,245 individuals (58% men) were
incident cases of type 1 diabetes in 2007–2011.
This analysis included the PDR, DISS and NDR. Incidence
rates were calculated separately in each register and collec-
tively by capture–recapture methods.
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Procedures We calculated incidence rates in the NDR
(20–34 year olds for 2006–2011), the DISS (15–34 year olds
for 2006–2009) and the PDR (0–34 year olds for 2007–2011)
separately.
We used a three-sample capture–recapture procedure to
estimate the level of ascertainment in the NDR, the DISS
and the PDR [21, 22]. We used a sample of all cases in the
20–34 age group with disease onset in 2009; the three registers
overlap for these populations, and the differences in the indi-
vidual incidence rates were smallest in 2009. Ascertainment
for each register was calculated as the actual number of cases
divided by the capture–recapture estimate. We also used the
capture–recapture method to estimate new incidence rates by
age group and sex in 2007–2009 (all three sources were
available for this period).
Chapman’s estimators were used for pairwise comparison
of registers. Pairwise estimates should be similar if sources are
independent [23, 24]. Log-linear models, which allow explo-
ration and incorporation of dependence and heterogeneity,
were used to estimate true population size. Our estimated level
of ascertainment and incidence rates is based on the best-
fitting log-linear model [21, 22]. We also used the sample
coverage approach, which is able to estimate population size
and dependence (the latter is modelled by the coefficient of
covariation [CCV]) [25].
Approved by the Central Ethical Review Board at the
University of Gothenburg, the study was conducted in accor-
dance with the principles of the Declaration of Helsinki.
Statistical analyses were performed with SAS V.9.3 (SAS
Institute, Cary, NC, USA) and R (R Foundation for Statistical
Computing).
Results
In terms of the proxy for diagnosis of type 1 diabetes, 91% of
the cases identified in the PDR among the 18–34 age group
could be matched in the NDR. Ninety-one per cent of the
cases were classified as type 1 diabetes in the NDR. When the
analysis was restricted to patients aged 18–30, 94% of cases
were classified as type 1 diabetes.
Given the level of ascertainment in 2009 for 20–34 year
olds, 151 cases were reported in the DISS, 312 in the NDR,
406 in the PDR and 475 altogether. Chapman’s estimates were
503 (PDR and NDR), 380 (NDR and DISS) and 457 (PDR
and DISS). The results suggest positive dependence between
the NDR and DISS, since it is lower than other pairwise
estimates. Disregarding dependence, the sample coverage ap-
proach estimated 504 (95% CI 492, 523) patients in the
population, while the log-linear model estimated 520 (95%
CI 504, 539). The sample coverage approach indicated a slight
dependence between the PDR and DISS (CCV assuming
independent sources 0.10; CCV assuming dependent sources
0.20) and no dependence between the NDR and PDR (CCV
assuming independent sources 0.00; CCV assuming depen-
dent sources 0.10). The dependence was stronger between the
NDR and DISS (CCV assuming independent sources 0.33;
CCV assuming dependent sources 0.45). Heterogeneity in
capture probabilities was revealed in both log-linear models
and the sample coverage approach. Thus, incorporating both
dependency and heterogeneity resulted in better-fitting
log-linear models. The best-fitting log-linear model,
which included the interaction between the NDR and
DISS, generated an estimate of 528 (95% CI 508, 554)
patients in the population. Thus, the level of ascertain-
ment was 29% in the DISS, 59% in the NDR and 77%
in the PDR. The sample coverage approach for depen-
dent sources generated an estimate of 551 (95% CI 524,
594) patients. The level of ascertainment was also calcu-
lated for 2007 and 2008; the results were very similar.
Table 1 and Fig. 1 present incidence rates obtained in
separate registers and by means of capture–recapture methods
using log-linear models (see electronic supplementary material
(ESM) for tables and figures by sex). Please refer to the tables
and figures for the details of incidence rates. For patients aged
14 and younger, the incidence rates obtained in the PDR were
very similar to those reported by the SCDR in 2005–2007 [19].
For the 15–19 age group, we had data from the PDR and DISS
only, the results showing that incidence rates are two to three
times higher in the PDR than in the DISS. For the 20–34 age
group, we compared all three registers separately, as well as
their combined capture–recapture estimates (2007–2009). In
terms of the separate registers, the DISS had the lowest inci-
dence and the PDR had the highest (generally twice as high).
However, the highest incidence rates were obtained by means
of the capture–recapture method. The incidence rate in the
PDR among 20–24 year olds in 2009 was 26.5 (95% CI
22.3, 30.6) per 100,000 person-years, while the capture–recap-
ture estimate was 31.2 (95% CI 26.7, 35.7) per 100,000
person-years.
In the PDR, the mean age at diagnosis for women de-
creased significantly (p<0.001) from 15.6 for 2007, 15.6 for
2008, 14.8 for 2009, 14.3 for 2010 to 14.1 for 2011. The mean
age at diagnosis for men was 16.7 for 2007, 16.0 for 2008,
15.8 for 2009, 15.6 for 2010 and 15.9 for 2011, with a non-
significant analysis of variance (p=0.060).
Discussion
Sweden and Finland manage some of the largest registers of
diabetes care and research. Given that the two countries also
have the highest incidence rate of type 1 diabetes in the world,
their reports are important [3]. Two out of three noteworthy
studies supporting a left shift in the age of onset without an
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increase in cumulative incidence are Swedish. These studies
were based on the DISS, which includes 15–34 year olds, and
the SCDR, which includes patients aged 14 and younger [8,
9]. The third study is from Belgium, a country with rather a
low incidence [10]. Reports from Finland for 1992–2001 [11],
Italy for 1984–2004 [12] and the UK for 1991–1999 [13], on
the other hand, indicate increasing or stable incidence in
patients aged 39 and younger.
We compared three nationwide Swedish registers separate-
ly and collectively by means of a capture–recapture method in
order to reassess the validity of previous reports and estimate
new incidence rates. Our analysis showed that the DISS
register had a level of ascertainment of ~29% for 2007–
2009, which is much too low to ensure reliable epidemiolog-
ical data. The DISS had better ascertainment earlier; the total
number of reported cases has decreased from 367 in 1983, 357
in 1993, 329 in 2003 and 216 in 2009. Our results should
seriously call into question previous Swedish reports on the
subject. It also suggests that epidemiological evidence
supporting the spring harvest theorymay have to be discarded.
However, it does not negate the theory per se, given that other
observations support it, as discussed comprehensively byGale
[1]. The same author proposes that a large multinational study
to explore the prevalence of islet autoantibodies in the back-
ground population should resolve the issue beyond dispute.
The argument is that type 1 diabetes rarely develops in the
absence of islet autoantibodies, and their prevalence in the
background population should reflect whether initiating fac-
tors determine the difference in incidence between popula-
tions. Conversely, equal antibody prevalence supports differ-
ent rates of disease progression. However, previous reports
from Sweden have underestimated the incidence rate of type 1
diabetes in the 15–34 age group.
We hypothesised that incidence rates could be monitored
solely via a proxy for diagnosis of type 1 diabetes in the PDR.
Using the PDR, we found that the incidence rate in the 15–34
age group was two to three times higher than in the DISS. The
PDR showed that incidence rates in young people were equal
to those in children aged 0–4 years. The proxy for diagnosis
was scrutinised and appeared to be reliable. The method’s
ascertainment capability was assessed by comparing inci-
dence rates in patients aged 14 and younger with figures from
the SCDR (2007–2009), which has an almost 100% level of
ascertainment; the results were very similar [19]. We showed
that the risk of including other types of diabetes was very
small: 91% of cases identified in the PDR for the 18–34 age
group could be recaptured in the NDR, where 91% were
classified as type 1 diabetes. When only 18–30 year olds were
considered, 94% were classified as having type 1 diabetes.
However, incidence rates and population sizes estimated by
the capture–recapture method were higher than in the PDR.
We note the difference in the nature of the three registers used
by our study. All three registers are nationwide. Data entry in
the NDR and DISS depends on the active participation of
clinics, as well as patient consent. Our analysis showed de-
pendence with regard to entry in the NDR and DISS, perhaps
reflecting patterns of clinical practice (i.e. differing proclivities
to engage in research and conduct quality assurance projects).
However, entry in the PDR is a passive and inevitable conse-
quence of the disease. All individuals with type 1 diabetes
must receive insulin, and it is impossible to do so in Sweden
without having been entered in the PDR. Thus, regardless of
entry in the various registers, all patients will be referred to the
PDR, but the PDR does not issue referrals. The PDR includes
virtually every Swede with type 1 diabetes. The delay from
disease onset to receipt of the first prescription for insulin
should be no more than 2–10 days. Moreover, classification
of the type of diabetes differs among the three registers.
Misclassification leads to inclusion of other types of diabetes,
which inflates the estimated population, particularly if the
NDR and DISS have low levels of ascertainment. This could
explain why incidence rates and population sizes obtained via
capture–recapture methods were higher than those in the
PDR.
Given the nature of the disease and inevitable entry in the
PDR, we believe that our proxy for diagnosis in the PDR
(particularly for patients aged 30 and younger) is a reliable and
feasible approach to future monitoring. However, the method
is not flawless in young adults. Whereas type 1 diabetes in
childhood often involves a straightforward diagnosis, autoim-
mune diabetes in adults is poorly defined [26] despite reports
indicating that 25–50% of type 1 diabetes cases are diagnosed
in adults [27] and 5–15% of adults diagnosed with type 2
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Fig. 1 Incidence rates per 100,000 person-years by age group and
register in 2009 (men and women). Data from the NDR, DISS, PDR
and the capture–recapture method included all three sources. Data from
the SCDR (2005–2007) are also presented for comparison purposes;
these data came from Berhan et al [19]
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increasing prevalence of obesity in adolescents and young
adults blurs the picture further. Thus, the specificity of the
PDR could be improved by including islet autoantibodies,
perhaps by linking PDR data to research and quality assurance
registers by means of such information.
The scientific community needs to establish cost-
effective, standardised and reliable methods for monitoring
type 1 diabetes—including adolescents and young adults—
in large geographic areas. Our study illustrates the chal-
lenges and opportunities associated with use of the PDR
to monitor the epidemiology of type 1 diabetes.
In conclusion, this study calls into question previous
evidence supporting a left shift in age of onset without
an increase in cumulative incidence. We report that the
incidence of type 1 diabetes is two to three times higher
in 15–34 year olds. Our capture–recapture estimates are
likely to be inflated because of misclassification of the
type of diabetes in the sources we included. We believe
that the PDR is probably the gold standard for moni-
toring the incidence of type 1 diabetes, particularly in
patients aged 30 and younger. This method is feasible,
reliable and cost-effective.
Limitations This study was limited to a relatively short period
of time, making it difficult to draw any conclusions about
trends. Moreover, we do not present evidence against the
spring harvest theory, we simply discard evidence supporting
it.
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